- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Liquidia Technologies Inc (LQDA)
Liquidia Technologies Inc stock price live, this page displays NASDAQ LQDA stock exchange data. View the LQDA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Liquidia Technologies Inc real time stock price chart below.
What Is the Liquidia Technologies Inc Stock Price Today?
The Liquidia Technologies Inc stock price today is 42.360.
What Is the Stock Symbol for Liquidia Technologies Inc?
The stock symbol for Liquidia Technologies Inc is "LQDA."
What Stock Exchange Does Liquidia Technologies Inc Trade On?
Liquidia Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Liquidia Technologies Inc a Good Stock to Buy?
Determining whether Liquidia Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LQDA quote. (ISIN: US53635D2027)
What Is the Liquidia Technologies Inc Stock Price Today?
The Liquidia Technologies Inc stock price today is 42.360.
What Is the Stock Symbol for Liquidia Technologies Inc?
The stock symbol for Liquidia Technologies Inc is "LQDA."
What Stock Exchange Does Liquidia Technologies Inc Trade On?
Liquidia Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Liquidia Technologies Inc a Good Stock to Buy?
Determining whether Liquidia Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LQDA quote. (ISIN: US53635D2027)
42.360
-0.680(-1.58%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.570
43.200
52 wk Range
11.260
46.670
LQDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.57043.200
52 wk Range
11.26046.670
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LQDA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
43.000
Upside
+1.51%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Form 13G Liquidia Corporation For: 9 February
- Investing.com
- Form 13G Liquidia Corporation For: 9 February
- Investing.com
- Liquidia corp general counsel sells $1m in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Liquidia Technologies Inc Company Profile
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Liquidia Technologies Inc Earnings Call Summary for Q3/2025
- Liquidia Technologies (LQDA) reported Q3 2025 EPS of -$0.04 vs -$0.41 forecast, with revenue of $54.34M exceeding expectations by 196.45%, driving stock up 11.49% pre-market.
- The company achieved positive adjusted EBITDA of $10.1M and its first month of positive net cash flow in September, with $157.5M cash on hand.
- Utrepia's launch has significantly penetrated the inhaled prostacyclin therapy market, with CEO Roger Jeffs stating it's 'redefining expectations for inhaled delivery of treprostinil.'
- Future plans include clinical studies for transitioning PAH patients, potential studies in IPF/PPF, development of sustained-release formulation L606, and preparation for the global RESPIRE study.
- Ongoing litigation with United Therapeutics remains a key risk, with judicial decisions expected between now and Q1 2026 potentially impacting market position.
Last Updated: 11/03/2025, 10:42 PM
Read Full TranscriptCompare LQDA to Peers and Sector
Metrics to compare | LQDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLQDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −30.2x | −3.2x | −0.5x | |
PEG Ratio | −3.60 | −0.04 | 0.00 | |
Price/Book | 169.8x | 2.2x | 2.6x | |
Price / LTM Sales | 54.1x | 3.7x | 3.3x | |
Upside (Analyst Target) | 11.5% | 63.9% | 45.6% | |
Fair Value Upside | Unlock | 7.9% | 5.8% | Unlock |
Analyst Ratings
7 Buy
0 Hold
1 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 43.000
(+1.51% Upside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
-0.04 / -0.41
Revenue / Forecast
54.34M / 18.33M
People Also Watch
FAQ
What Is the Liquidia Technologies (LQDA) Stock Price Today?
The Liquidia Technologies stock price today is 42.360
What Stock Exchange Does Liquidia Technologies Trade On?
Liquidia Technologies is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Liquidia Technologies?
The stock symbol for Liquidia Technologies is "LQDA."
What Is the Liquidia Technologies Market Cap?
As of today, Liquidia Technologies market cap is 3.68B.
What Is Liquidia Technologies's Earnings Per Share (TTM)?
The Liquidia Technologies EPS (TTM) is -1.45.
When Is the Next Liquidia Technologies Earnings Date?
Liquidia Technologies will release its next earnings report on Mar 11, 2026.
From a Technical Analysis Perspective, Is LQDA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Liquidia Technologies Stock Split?
Liquidia Technologies has split 0 times.
How Many Employees Does Liquidia Technologies Have?
Liquidia Technologies has 170 employees.
What is the current trading status of Liquidia Technologies (LQDA)?
As of Feb 09, 2026, Liquidia Technologies (LQDA) is trading at a price of 42.360, with a previous close of 43.040. The stock has fluctuated within a day range of 41.570 to 43.200, while its 52-week range spans from 11.260 to 46.670.
What Is Liquidia Technologies (LQDA) Price Target According to Analysts?
The average 12-month price target for Liquidia Technologies is USD43.000, with a high estimate of USD55 and a low estimate of USD16. 7 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +1.51% Upside potential.
What Is the LQDA Premarket Price?
LQDA's last pre-market stock price is 43.490. The pre-market share volume is 1,480.000, and the stock has decreased by 0.450, or 1.050%.
What Is the LQDA After Hours Price?
LQDA's last after hours stock price is 43.190, the stock has decreased by 0.150, or 0.350%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.